{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:28:44Z","timestamp":1782235724682,"version":"3.54.5"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sarcoidosis is a systemic inflammatory disease with a predilection for the respiratory system. Although most patients enter remission and have good long-term outcomes, up to 20% develop fibrotic lung disease, whereby granulomatous inflammation evolves to pulmonary fibrosis. There are several radiographic patterns of pulmonary fibrosis in sarcoidosis; bronchial distortion is common, and other patterns, including honeycombing, are variably observed. The development of pulmonary fibrosis is associated with significant morbidity and can be fatal. Dyspnea, cough, and hypoxemia are frequent clinical manifestations. Pulmonary function testing often demonstrates restriction from parenchymal involvement, although airflow obstruction from airway-centric fibrosis is also recognized. Complications of fibrotic pulmonary sarcoidosis include pulmonary hypertension from capillary obliteration and chronic aspergillus disease, with hemoptysis a common and potentially life-threatening manifestation. Immunosuppression is not always indicated in end-stage sarcoidosis. Lung transplantation should be considered for patients with severe fibrotic pulmonary sarcoidosis, as mortality is high in these patients.<\/jats:p>","DOI":"10.1513\/annalsats.201303-069fr","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T10:04:25Z","timestamp":1392372265000},"page":"362-370","source":"Crossref","is-referenced-by-count":125,"title":["Pulmonary Fibrosis in Sarcoidosis. Clinical Features and Outcomes"],"prefix":"10.1093","volume":"10","author":[{"given":"Karen C.","family":"Patterson","sequence":"first","affiliation":[{"name":"Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania, Philadelphia, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Strek","sequence":"additional","affiliation":[{"name":"Section of Pulmonary and Critical Care, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"key":"2026012303564953800_bib1","first-page":"736","article-title":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303564953800_bib2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years\u2019 observation","volume":"2","author":"Scadding","year":"1961","journal-title":"BMJ"},{"key":"2026012303564953800_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2026012303564953800_bib4","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303564953800_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303564953800_bib6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"2026012303564953800_bib7","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.lpm.2012.03.018","article-title":"Pathogenesis of sarcoidosis","volume":"41","author":"Muller-Quernheim","year":"2012","journal-title":"Presse Med"},{"key":"2026012303564953800_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1513\/pats.200606-130MS","article-title":"Role of CD4+ T cells in sarcoidosis","volume":"4","author":"Grunewald","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"2026012303564953800_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.2003.01075.x","article-title":"Treatment of sarcoidosis\u2013from a basic science point of view","volume":"253","author":"Moller","year":"2003","journal-title":"J Intern Med"},{"key":"2026012303564953800_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2559.2006.02546.x","article-title":"Pathological diagnosis of granulomatous lung disease: a review","volume":"50","author":"El-Zammar","year":"2007","journal-title":"Histopathology"},{"key":"2026012303564953800_bib11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"2026012303564953800_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2010.06.017","article-title":"Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction","volume":"137","author":"Pechkovsky","year":"2010","journal-title":"Clin Immunol"},{"key":"2026012303564953800_bib13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2026012303564953800_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trsl.2012.03.005","article-title":"The clinical and immunologic features of pulmonary fibrosis in sarcoidosis","volume":"160","author":"Patterson","year":"2012","journal-title":"Transl Res"},{"key":"2026012303564953800_bib15","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2214\/ajr.174.6.1741751","article-title":"Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function","volume":"174","author":"Abehsera","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"2026012303564953800_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.127.1.185","article-title":"Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis","volume":"127","author":"Akira","year":"2005","journal-title":"Chest"},{"key":"2026012303564953800_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0009-9260(96)80011-0","article-title":"Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT","volume":"51","author":"Padley","year":"1996","journal-title":"Clin Radiol"},{"key":"2026012303564953800_bib18","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1148\/rg.306105512","article-title":"Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation","volume":"30","author":"Criado","year":"2010","journal-title":"Radiographics"},{"key":"2026012303564953800_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2214\/AJR.10.4873","article-title":"Honeycomb lung: history and current concepts","volume":"196","author":"Arakawa","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"2026012303564953800_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1369\/jhc.2009.953067","article-title":"Intralobular pulmonary lymphatic distribution in normal human lung using D2\u201340 antipodoplanin immunostaining","volume":"57","author":"Kambouchner","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"2026012303564953800_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"key":"2026012303564953800_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1183\/09031936.00150609","article-title":"Chronic interstitial pneumonitis in end-stage sarcoidosis","volume":"35","author":"Shigemitsu","year":"2010","journal-title":"Eur Respir J"},{"key":"2026012303564953800_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-3-8","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Meltzer","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"2026012303564953800_bib24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1164\/ajrccm.157.4.9707039","article-title":"Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification","volume":"157","author":"Katzenstein","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303564953800_bib25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"2026012303564953800_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/msj.20090","article-title":"\u201cEnd-stage\u201d pulmonary fibrosis in sarcoidosis","volume":"76","author":"Teirstein","year":"2009","journal-title":"Mt Sinai J Med"},{"key":"2026012303564953800_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiology.209.3.9844661","article-title":"Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT","volume":"209","author":"Hansell","year":"1998","journal-title":"Radiology"},{"key":"2026012303564953800_bib28","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/ajrccm.149.4.8143052","article-title":"Outcome of the treatment for sarcoidosis","volume":"149","author":"Hunninghake","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303564953800_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00408-011-9316-1","article-title":"Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis","volume":"189","author":"Lopes","year":"2011","journal-title":"Lung"},{"key":"2026012303564953800_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0954-6111(06)80211-8","article-title":"Airflow limitation in sarcoidosis\u2013a study of pulmonary function in 107 patients with newly diagnosed disease","volume":"85","author":"Harrison","year":"1991","journal-title":"Respir Med"},{"key":"2026012303564953800_bib31","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1378\/chest.08-2569","article-title":"Airway involvement in sarcoidosis","volume":"136","author":"Polychronopoulos","year":"2009","journal-title":"Chest"},{"key":"2026012303564953800_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/crad.1999.0366","article-title":"Air trapping in sarcoidosis on computed tomography: correlation with lung function","volume":"55","author":"Davies","year":"2000","journal-title":"Clin Radiol"},{"key":"2026012303564953800_bib33","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1378\/chest.130.6.1851","article-title":"Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis","volume":"130","author":"Handa","year":"2006","journal-title":"Chest"},{"key":"2026012303564953800_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.122.1.233","article-title":"Outcomes for patients with sarcoidosis awaiting lung transplantation","volume":"122","author":"Shorr","year":"2002","journal-title":"Chest"},{"key":"2026012303564953800_bib35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"key":"2026012303564953800_bib36","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1183\/09031936.00175511","article-title":"Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation","volume":"39","author":"Shlobin","year":"2012","journal-title":"Eur Respir J"},{"key":"2026012303564953800_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of sarcoidosis","volume":"28","author":"Rosen","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012303564953800_bib38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1148\/rg.322115024","article-title":"AIRP best cases in radiologic-pathologic correlation: pulmonary sarcoidosis complicated by aspergilloma formation","volume":"32","author":"Kantartzis","year":"2012","journal-title":"Radiographics"},{"key":"2026012303564953800_bib39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09059180.00001011","article-title":"Pulmonary aspergillosis: a clinical review","volume":"20","author":"Kousha","year":"2011","journal-title":"Eur Respir Rev"},{"key":"2026012303564953800_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00408-011-9280-9","article-title":"Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature","volume":"189","author":"Pena","year":"2011","journal-title":"Lung"},{"key":"2026012303564953800_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2214\/ajr.174.1.1740051","article-title":"Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients","volume":"174","author":"Franquet","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"2026012303564953800_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(69)90150-8","article-title":"Sarcoidosis and aspergilloma","volume":"47","author":"Israel","year":"1969","journal-title":"Am J Med"},{"key":"2026012303564953800_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2010.3641","article-title":"A severe case of multisystem sarcoidosis complicated by aspergillosis and aspergillomas","author":"Zoumot","year":"2011","journal-title":"BMJ Case Rep"},{"key":"2026012303564953800_bib44","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.ijid.2009.07.011","article-title":"Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases","volume":"14","author":"Nam","year":"2010","journal-title":"Int J Infect Dis"},{"key":"2026012303564953800_bib45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","article-title":"Practice guidelines for diseases caused by Aspergillus","volume":"30","author":"Stevens","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2026012303564953800_bib46","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.12-1784","article-title":"A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma","volume":"143","author":"Kravitz","year":"2013","journal-title":"Chest"},{"key":"2026012303564953800_bib47","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1378\/chest.82.4.430","article-title":"Sarcoidosis and aspergilloma. The role of surgery","volume":"82","author":"Israel","year":"1982","journal-title":"Chest"},{"key":"2026012303564953800_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-2007-1013823","article-title":"Surgical treatment of pulmonary and pleuro-pulmonary Aspergillus disease","volume":"41","author":"Wex","year":"1993","journal-title":"Thorac Cardiovasc Surg"},{"key":"2026012303564953800_bib49","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review","volume":"37","author":"Denning","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026012303564953800_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026012303564953800_bib51","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1378\/chest.12-1060","article-title":"Acute pulmonary exacerbations of sarcoidosis","volume":"142","author":"Panselinas","year":"2012","journal-title":"Chest"},{"key":"2026012303564953800_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1440-1843.2007.01206.x","article-title":"The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis","volume":"13","author":"Judson","year":"2008","journal-title":"Respirology"},{"key":"2026012303564953800_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-92-3-361","article-title":"Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis","volume":"92","author":"DeRemee","year":"1980","journal-title":"Ann Intern Med"},{"key":"2026012303564953800_bib54","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1378\/chest.11-0324","article-title":"Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007","volume":"140","author":"Swigris","year":"2011","journal-title":"Chest"},{"key":"2026012303564953800_bib55","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1378\/chest.129.6.1599","article-title":"Pleural effusions in a series of 181 outpatients with sarcoidosis","volume":"129","author":"Huggins","year":"2006","journal-title":"Chest"},{"key":"2026012303564953800_bib56","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/thx.50.12.1324","article-title":"Sarcoidosis presenting with chylothorax","volume":"50","author":"Jarman","year":"1995","journal-title":"Thorax"},{"key":"2026012303564953800_bib57","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1183\/09031936.06.00105805","article-title":"Corticosteroid treatment in sarcoidosis","volume":"28","author":"Grutters","year":"2006","journal-title":"Eur Respir J"},{"key":"2026012303564953800_bib58","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jama.287.10.1301","article-title":"Corticosteroid therapy in pulmonary sarcoidosis: a systematic review","volume":"287","author":"Paramothayan","year":"2002","journal-title":"JAMA"},{"key":"2026012303564953800_bib59","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303564953800_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2466-12-57","article-title":"A predictive tool for an effective use of 18F-FDG PET in assessing activity of sarcoidosis","volume":"12","author":"Mostard","year":"2012","journal-title":"BMC Pulm Med"},{"key":"2026012303564953800_bib61","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s11547-012-0827-5","article-title":"Follow-up in pulmonary sarcoidosis: comparison between HRCT and pulmonary function tests","volume":"117","author":"Gafa","year":"2012","journal-title":"Radiol Med (Torino)"},{"key":"2026012303564953800_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00330-004-2480-4","article-title":"CT findings in severe thoracic sarcoidosis","volume":"15","author":"Hennebicque","year":"2005","journal-title":"Eur Radiol"},{"key":"2026012303564953800_bib63","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"2026012303564953800_bib64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00408-007-9008-z","article-title":"Comorbid illnesses and chest radiographic severity in African-American sarcoidosis patients","volume":"185","author":"Westney","year":"2007","journal-title":"Lung"},{"key":"2026012303564953800_bib65","first-page":"154","article-title":"Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients","volume":"19","author":"Lewis","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012303564953800_bib66","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-2007-970339","article-title":"Lung transplantation in sarcoidosis","volume":"28","author":"Shah","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012303564953800_bib67","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0012-3692(15)37649-2","article-title":"Predicting mortality in patients with sarcoidosis awaiting lung transplantation","volume":"124","author":"Shorr","year":"2003","journal-title":"Chest"},{"key":"2026012303564953800_bib68","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1378\/chest.125.3.990","article-title":"Sarcoidosis, race, and short-term outcomes following lung transplantation","volume":"125","author":"Shorr","year":"2004","journal-title":"Chest"},{"key":"2026012303564953800_bib69","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1378\/chest.120.3.873","article-title":"Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation","volume":"120","author":"Arcasoy","year":"2001","journal-title":"Chest"},{"key":"2026012303564953800_bib70","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1378\/chest.121.1.128","article-title":"Outcome of lung transplantation in patients with mycetomas","volume":"121","author":"Hadjiliadis","year":"2002","journal-title":"Chest"},{"key":"2026012303564953800_bib71","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-3062.2011.00615.x","article-title":"Successful double lung transplantation in a patient with bilateral pulmonary and sinus aspergillomas","volume":"13","author":"Minces","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"2026012303564953800_bib72","first-page":"117","article-title":"Bronchiolitis obliterans syndrome and survival following lung transplantation for patients with sarcoidosis","volume":"25","author":"Wille","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012303564953800_bib73","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.201210-1865OC","article-title":"Clinical risk factors for primary graft dysfunction after lung transplantation","volume":"187","author":"Diamond","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303564953800_bib74","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/ajrccm\/148.5.1373","article-title":"Recurrence of sarcoidosis in pulmonary allograft recipients","volume":"148","author":"Johnson","year":"1993","journal-title":"Am Rev Respir Dis"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/10\/4\/362\/66552492\/annalsats_10_4_362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/10\/4\/362\/66552492\/annalsats_10_4_362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:57:08Z","timestamp":1769158628000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/10\/4\/362\/8432113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":74,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,8,1]]},"published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201303-069fr","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,8]]},"published":{"date-parts":[[2013,8,1]]}}}